NexImmune Inc (NEXI)
3.60
+0.14
(+4.05%)
USD |
NASDAQ |
May 10, 16:00
3.49
-0.11
(-3.06%)
After-Hours: 20:00
NexImmune Total Assets (Quarterly): 8.594M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.594M |
| September 30, 2023 | 14.56M |
| June 30, 2023 | 23.47M |
| March 31, 2023 | 30.66M |
| December 31, 2022 | 43.06M |
| September 30, 2022 | 57.67M |
| June 30, 2022 | 65.67M |
| March 31, 2022 | 78.31M |
| Date | Value |
|---|---|
| December 31, 2021 | 91.03M |
| September 30, 2021 | 104.54M |
| June 30, 2021 | 115.39M |
| March 31, 2021 | 126.57M |
| December 31, 2020 | 11.30M |
| September 30, 2020 | 6.694M |
| December 31, 2019 | 13.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.694M
Minimum
Sep 2020
126.57M
Maximum
Mar 2021
52.75M
Average
43.06M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Mind Medicine Inc | 275.53M |
| Candel Therapeutics Inc | 41.20M |
| Ventyx Biosciences Inc | 277.69M |
| NKGen Biotech Inc | 16.48M |
| CERo Therapeutics Holdings Inc | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.084M |
| Shareholders Equity (Quarterly) | 3.510M |